Loading clinical trials...
Loading clinical trials...
A Prospective Multicenter Single Arm Study to Assess the Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System for the Treatment of Subjects With Atherosclerotic Lesion(s)
Conditions
Interventions
Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System
Locations
17
United States
John Muir Medical Center
Concord, California, United States
Ascension Via Christi Hospitals Wichita
Wichita, Kansas, United States
North Shore University Hospital
Manhasset, New York, United States
Columbia University Irving Medical Center/New York Presbyterian Hospital
New York, New York, United States
Baylor Scott & White The Heart Hospital - Dallas
Dallas, Texas, United States
Ascension Texas Cardiovascular
Kyle, Texas, United States
Start Date
July 18, 2025
Primary Completion Date
September 1, 2027
Completion Date
September 1, 2031
Last Updated
March 31, 2026
NCT06863155
NCT05461729
NCT03854071
NCT05681702
NCT07444697
NCT01311323
Lead Sponsor
Teleflex
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions